Ozempic shows potential to help dialysis patients qualify for kidney transplants

medicalxpress.com

New research suggests weight loss medications like Ozempic could help dialysis patients become eligible for kidney transplants. The study found Semaglutide, the active ingredient in Ozempic, led to significant weight loss in dialysis patients, with nearly half becoming eligible for transplant waitlists. This offers a promising non-surgical option for patients facing obesity as a barrier to life-saving transplants, a common issue in end-stage kidney disease.


With a significance score of 5.2, this news ranks in the top 1% of today's 29322 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: